Pharma Insider Blows the Whistle on Bad Batches: That Level of Variability ‘Should Never Happen’

Via Vigilant Fox: That Level of Variability ‘Should Never Happen’ Have you wondered why some people seem perfectly fine after the COVID shot, whereas others suffered debilitating injuries? Well, not everyone was getting the same thing. Former pharmaceutical executive Sasha Latypova details the “extreme” variability among batches: “I was able to see that not only the adverse events were high, but the variability of them by batch was extreme, absolutely extreme. So some batch numbers had two or three reports, and some had 5000, 6000. That should never happen,” she attested. “If you think about it, if you’re buying Advil today, if you’re buying it today, and you’re buying it a month from now, your experience a month from now shouldn’t be 1000% different because that’s really dangerous.”

Full Video:

Published by markskidmore

Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.

Leave a Reply

%d bloggers like this: